Published October 6, 2015 | Version v1
Patent Open

Methods and compositions related to glucocorticoid receptor antagonists and breast cancer

Contributors

Patent applicant:

Description

Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating the activity of the glucocorticoid receptor in tumor cells. Other embodiment include methods of treating breast cancer cells, particularly, chemo-resistant cells, with a glucocorticoid receptor antagonist and an anticancer agent or compound.

Files

US9149485.pdf

Files (3.9 MB)

Name Size Download all
md5:68b75b72161b8d93b63696a9201f24f8
3.9 MB Preview Download

Additional details

Identifiers

Patent number
US 201414172051 A
Patent application number
US 9149485 B2
Other
oai:uchicago.tind.io:8154

Dates

Patent filed
2014-02-04

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine